tiprankstipranks
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
US Market

Avadel Pharmaceuticals (AVDL) Income Statement

Compare
717 Followers

Avadel Pharmaceuticals Income Statement

Last quarter (Q4 2024), Avadel Pharmaceuticals's total revenue was $50.41M, an increase of 159.14% from the same quarter last year. In Q4, Avadel Pharmaceuticals's net income was $-5.04M. See Avadel Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 169.12M$ 27.96M$ 0.00$ 0.00$ 22.33M
Gross Profit
$ 153.84M$ 27.12M$ -1.49M$ -815.00K$ 16.59M
Operating Expenses
$ 196.24M$ 164.97M$ 95.22M$ 85.60M$ 53.25M
Depreciation and Amortization
$ 2.68M$ 1.77M$ 1.49M$ 815.00K$ 1.69M
EBITDA
$ -42.40M$ -149.13M$ -97.60M$ -84.78M$ -34.97M
Operating Income
$ -42.40M$ -137.85M$ -98.56M$ -85.55M$ -36.66M
Other Income/Expenses
$ -6.68M$ -22.93M$ -12.88M$ -7.60M$ -10.90M
Pretax Income
$ -49.08M$ -160.78M$ -111.44M$ -93.14M$ -5.08M
Net Income
$ -48.83M$ -160.28M$ -137.46M$ -77.33M$ 7.03M
Per Share Metrics
Basic EPS
$ -0.51$ -2.00$ -2.29$ -1.32$ 0.13
Diluted EPS
$ -0.51$ -2.00$ -2.29$ -1.32$ 0.13
Weighted Average Shares Outstanding
95.14M 80.17M 60.09M 58.53M 53.00M
Weighted Average Shares Outstanding (Diluted)
95.14M 80.17M 60.09M 58.53M 54.94M
Currency in USD

Avadel Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis